ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $89 | -35.5% | 27,946 | +1.0% | 0.00% | – |
Q2 2023 | $138 | +0.7% | 27,680 | -0.4% | 0.00% | – |
Q1 2023 | $137 | -61.9% | 27,781 | -51.4% | 0.00% | – |
Q4 2022 | $360 | -99.9% | 57,197 | -0.1% | 0.00% | -100.0% |
Q3 2022 | $618,000 | +11.0% | 57,246 | +17.1% | 0.00% | 0.0% |
Q2 2022 | $557,000 | +24.9% | 48,866 | -0.2% | 0.00% | – |
Q1 2022 | $446,000 | -39.0% | 48,988 | +0.0% | 0.00% | -100.0% |
Q4 2021 | $731,000 | -42.1% | 48,966 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $1,263,000 | -17.6% | 49,137 | -16.4% | 0.00% | -50.0% |
Q2 2021 | $1,532,000 | -11.2% | 58,749 | +20.1% | 0.00% | 0.0% |
Q1 2021 | $1,726,000 | +39.9% | 48,900 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $1,234,000 | -26.5% | 48,900 | +9.9% | 0.00% | -50.0% |
Q3 2020 | $1,678,000 | -11.9% | 44,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,905,000 | +181.4% | 44,500 | +27.9% | 0.00% | +100.0% |
Q1 2020 | $677,000 | -25.1% | 34,800 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $904,000 | -16.7% | 34,800 | -12.6% | 0.00% | 0.0% |
Q3 2019 | $1,085,000 | +1.5% | 39,800 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,069,000 | +73.5% | 39,800 | +86.9% | 0.00% | 0.0% |
Q1 2019 | $616,000 | – | 21,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |